Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged between 18 and 80 years old (inclusive)
- People who have been diagnosed with colon adenocarcinoma (a specific type of colon cancer), confirmed through laboratory testing of tissue
- People who have had surgery to fully remove stage I, II, or III colorectal cancer
- People whose cancer has been classified at a specific level of spread (T1, T2, T3, or T4, and N0, N1, or N2 — confirm with trial site for what this means in your case)
- People who are eligible to receive 6 months of additional cancer treatment (chemotherapy) after surgery
- People who have given their full, voluntary, written agreement to take part
- People who agree to allow a sample of their tumour tissue to be used for research
- People who are enrolled in a social security or health insurance system
Who may not be able to join:
- Women who are pregnant or currently breastfeeding
- People who are legally unable to give consent, or whose physical, mental, social, or location-related circumstances would prevent them from completing the study
- People who have had another solid tumour (a different cancer) within the 3 years before joining the trial — with the exception of certain treated and controlled skin cancers or cervical cancer that had not spread
- People who are currently under a legal protection or guardianship measure (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hervé PERRIER, M.D, Hopital Saint Joseph Marseille
Phone: 04 88 73 10 70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of cases where the recommendations for patient care according to the Immunoscore® are considered beneficial compared to the standard care decision
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.